Latest Breaking News On - Sphera funds management - Page 1 : comparemela.com

CARGO Therapeutics (NASDAQ:CRGX) Shares Down 3 2%

CARGO Therapeutics (NASDAQ:CRGX) Shares Down 3 2%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jefferies financial groupTherapeutics incGroup plcNorges bankSphera funds managementNorthern trust corpTherapeutics company profileGoldman sachs group incCargo therapeutics incGet free reportGeneral group plcSachs groupTrust corp

Nova (NASDAQ:NVMI) Trading 3 6% Higher

Nova (NASDAQ:NVMI) Trading 3 6% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMillennium managementClal insurance enterprises holdings ltdNuveen asset managementNova ltdSphera funds managementInvesco ltdNova company profileGet free reportStock downInsurance enterprises holdings ltdFunds managementNova daily

Arbe Robotics Ltd (NASDAQ:ARBE) Short Interest Up 102 3% in March

Arbe Robotics Ltd. (NASDAQ:ARBE – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 704,900 shares, a growth of 102.3% from the March 15th total of 348,400 shares. Based on an average daily trading volume, of 143,100 […]

United statesSphera funds managementArbe robotics company profileNorthern trust corpArbe robotics ltdYd more investments ltdArbe roboticsGet free reportInvestments ltdTrust corpRobotics ltdArbe robotics daily

Disc Medicine (NASDAQ:IRON) Price Target Raised to $73 00 at Stifel Nicolaus

Disc Medicine (NASDAQ:IRON – Free Report) had its price target boosted by Stifel Nicolaus from $71.00 to $73.00 in a research note released on Monday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. IRON has been the subject of several other research reports. Wedbush reiterated an outperform rating and set a […]

United statesStifel nicolausCitadel advisorsFirst turn managementBlackrock incCantor fitzgeraldDisc medicine incVenture fund xlp atlasMorgan stanleySphera funds managementPerceptive advisorsDisc medicineFree reportModerate buyGet free reportVenture fund

Gracell Biotechnologies Inc (NASDAQ:GRCL) Given Consensus Recommendation of Hold by Brokerages

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) has received an average recommendation of “Hold” from the eight brokerages that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokerages […]

Piper sandlerStifel nicolausVenture partners investment advisorWells fargo companyGracell biotechnologies incSphera funds managementVivo capitalGracell biotechnologiesGet free reportFunds managementBay capital managementGet freeBiotechnologies incGracell biotechnologies dailyNasdaq grcl